Publications by authors named "Emi Dika"

Background/objectives: Despite advancements in early diagnosis and clinical practices guided by standardized care protocols, Merkel cell carcinoma (MCC) is marked by an unfavorable prognosis with a 5-year relative survival rate of 65%, based primarily on data collected prior to the introduction of immunotherapy. Regional nodal metastases affect 40-50% of MCC patients, while approximately 33% experience distant dissemination. Among these, bone and bone marrow metastases are particularly notable, although the characteristics and clinical implications of this metastatic disease in MCC remain poorly understood.

View Article and Find Full Text PDF

Background: Studies have found that few lesions clinically diagnosed as seborrheic keratosis (SK) revealed Cutaneous melanoma (CM) on histopathology. When CM mimics SK, they are defined as seborrheic keratosis-like melanoma (SKLM), and a delayed diagnosis and treatment can occur.

Methods: We conducted a retrospective descriptive, monocentric study of the epidemiological, clinical, videodermoscopy (VDS), and reflectance confocal microscopy (RCM) characteristics of histopathologically proven SKLM diagnosed between 2018 and 2024.

View Article and Find Full Text PDF

Cutaneous melanoma is one of the most lethal forms of skin cancer, and its incidence is increasing globally. Its diagnosis typically relies on manual histopathological examination, a process that is both complex and time consuming. In this study, we propose an automated diagnostic tool, capable of generating interpretable results to aid clinical decision-making.

View Article and Find Full Text PDF

/: Long-term outcome data of locally advanced basal cell carcinoma patients who achieve complete response (CR) on hedgehog pathway inhibitors (HHIs) are lacking, highlighting a gap in the identification of the predictors of tumor recurrence. We aimed to investigate the clinical and histological factors associated with locally advanced BCC recurrence after CR on HHIs. : We performed a retrospective multicenter observational study at 14 Italian tertiary referral centers (1 January 2016-1 March 2024).

View Article and Find Full Text PDF

Introduction: High-dose brachytherapy using a non-sealed Rhenium resin (Re) is a new treatment option for difficult-to-treat basal cell carcinoma (BCC) that ensures a radical oncological outcome minimizing side effects.

Objectives: The aim of this retrospective study was to evaluate the clinical efficacy of high-dose standardized brachytherapy using an unsealed Re in the management of difficult-to-treat BCCs and to evaluate the risk factors of relapses.

Methods: Between October 2017 and December 2022, patients affected by difficult-to-treat BCC were selected.

View Article and Find Full Text PDF

Background: Melanoma of the sole is an aggressive rare form, often diagnosed late. Plantar atypical nevi (pAN) are frequently misdiagnosed as plantar early melanomas (pEM) and therefore excised. Our aim was to develop a clinical-dermoscopic risk-scoring model to help discriminate these plantar atypical melanocytic lesions (pAMLs).

View Article and Find Full Text PDF

Photodynamic therapy (PDT) has been shown to be a safe and highly effective treatment for Bowen's disease. We report two cases of patients with palpebral Bowen's disease successfully treated with PDT. Although surgery remains the preferred treatment for challenging sites such as the periocular area, PDT in select cases may represent a good therapeutic option.

View Article and Find Full Text PDF

The identification of predictive factors for sentinel lymph node (SLN) positivity in melanoma patients is crucial for accurate staging, prognosis, and personalized therapeutic decisions. This review synthesizes recent advancements in molecular and clinicopathological predictors, with a particular focus on liquid biopsy and gene expression profiling (GEP) tools. Emerging evidence highlights the significant role of miRNAs in melanoma progression, metastatic potential, and lymphatic spread.

View Article and Find Full Text PDF
Article Synopsis
  • - Melanoma cases are on the rise, leading to frequent updates in guidelines for diagnosis, staging, and treatment; recent approvals now include adjuvant therapy for stage IIb/c melanoma.
  • - A study involving 92 melanoma patients revealed that those with stage IIb/c have a later age of diagnosis and a higher occurrence of specific characteristics like ulceration and angiotropism compared to stage IIIa patients.
  • - While not statistically significant, stage IIb/c patients showed a higher rate of metastasis over a 5-year period (15%) compared to those with stage IIIa melanoma (4%), highlighting the potential benefits of adjuvant immunotherapy for stage IIb/c patients.
View Article and Find Full Text PDF

Cutaneous melanoma (CM) and pancreatic cancer are aggressive tumors whose incidences are rapidly increasing in the last years. This review aims to provide a complete and update description about mutational landscape in CM and pancreatic cancer, focusing on similarities of these two apparently so different tumors in terms of site, type of cell involved, and embryonic origin. The familial forms of CM and pancreatic cancers are often characterized by a common mutated gene, namely CDKN2A.

View Article and Find Full Text PDF
Article Synopsis
  • Advanced melanoma treatments have evolved with targeted therapies and immunotherapies, which significantly impact management but also lead to increased skin toxicities during treatment.
  • A study in Bologna identified that 37.5% of 202 patients treated for melanoma developed cutaneous adverse events, primarily linked to drugs like ipilimumab and nivolumab.
  • Most skin reactions were low-grade and manageable, but some resulted in severe conditions, highlighting the importance of recognizing and treating these toxicities to ensure patient quality of life.
View Article and Find Full Text PDF
Article Synopsis
  • Diagnosing atypical pigmented facial lesions (aPFLs) is difficult for dermatologists and crucial for patient care, as incorrect diagnoses can lead to mismanagement and delays in treatment.
  • The study compared machine learning and deep learning models to improve diagnostic accuracy of aPFLs using 1197 dermoscopic images classified into seven categories, focusing on the potential role of AI in supporting clinicians.
  • Results showed that while dermatologists were 71.2% accurate in identifying malignant versus benign lesions, their accuracy dropped to 42.9% when distinguishing among specific lesions, highlighting the complexity of aPFL evaluations.
View Article and Find Full Text PDF
Article Synopsis
  • External ear lentigo maligna/lentigo melanoma (LM/LMM) accounts for 1%-4% of all primary skin melanomas, and dermoscopy has greatly improved early detection over the last 20 years, especially with new diagnostic features like perifollicular linear projections (PLP).
  • The study focused on 19 patients from the Oncologic Dermatology Unit in Bologna, investigating dermoscopic traits and the patients' clinical data, revealing that most patients were older males with an average age of 69.8 years.
  • Results indicated that lentigo melanoma (LMM) tends to be larger (more than twice the size) and more commonly presents in older patients than lentigo maligna (LM), with
View Article and Find Full Text PDF

Background: Basosquamous carcinoma (BSC) is a rare and aggressive nonmelanoma skin cancer (NMSC) that exhibits features of both BCC and squamous cell carcinoma (SCC). The gold standard for diagnosis is histopathological examination. BSC is often challenging to diagnose and manage due to its mixed histological features and potential for aggressive behavior AIM: To identify specific features aiding clinicians in differentiating BSCs using non-invasive diagnostic techniques.

View Article and Find Full Text PDF